Novoheart Holdings - M&A Summary and Business Overview

Life ScienceCompany

Novoheart Holdings M&A Summary

Novoheart Holdings has acquired 1 company, including 1 in the last 5 years.

Novoheart Holdings’ largest acquisition to date was in 2019, when it acquired Xellera Therapeutics for $26M. The Company’s most targeted sectors include life science (100%).

Novoheart Holdings Business Overview

Where is Novoheart Holdings headquartered?

Novoheart Holdings is headquartered in Vancouver, British Columbia.

What sector is Novoheart Holdings in?

Novoheart Holdings is a life science company.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1

Novoheart Holdings, Inc.

800 West Pender Street Suite 1430,
Vancouver, British Columbia V6C 2V6
Canada,
(604) 398 3170
www.novoheart.com

Novoheart Holdings, Inc. is a global stem cell biotechnology company pioneering an array of next-generation human heart tissue prototypes. Novoheart Holdings, Inc. have engineered miniature living human heart pumps that can revolutionize drug discovery, helping to save time and money for developing new therapeutics. Also known as 'human heart-in-a-jar', Novoheart’s bio-artificial human heart constructs are created using state-of-the-art and proprietary stem cell and bioengineering approaches and are utilized by drug developers for accurate preclinical testing as to the effectiveness and safety of new drugs, maximizing the successes in drug discovery whilst minimizing costs and harm caused to patients. Novoheart Holdings is based in Vancouver, British Columbia.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 1 - - - - - 1
vol $26M $26M
Sell (0.0/yr) # - - - - - - 0
  1

Most Recent M&A

Company Date Value Type
Xellera Therapeutics Ltd. 2019-05-28 26M CAD Add-on Acquisition
Hong Kong, China · www.xelleratherapeutics.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) 26M (100%) - -
Total 1 $26M - -

By Geo

State/Country Buy Value Sell Value
China 1 26M - -
Total 1 $26M - -

Deal Values

buy # Total
< $100M 1 $26M
TOTAL $26M
Largest Xellera Therapeutics Ltd.
$26M (2019-05-28)

 Subscribe to unlock this and 202,314
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.